NCT06917326 is a NA clinical trial of Monitoring in RDS of Prematurity, sponsored by Neola Medical AB.

Who is sponsoring NCT06917326?

NCT06917326 is sponsored by Neola Medical AB.

What drugs are being tested in NCT06917326?

Interventions in NCT06917326: Monitoring.

What condition does NCT06917326 study?

NCT06917326 studies RDS of Prematurity, Preterm Birth, Lung Diseases.

Is NCT06917326 still recruiting?

NCT06917326 is currently completed. Last updated 18 March 2026.

Last reviewed 2026-03-18 · How we verify

NCT06917326

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

Completed NA Last updated 18 March 2026

What this trial tests

NA trial testing Monitoring in RDS of Prematurity in 10 participants. Completed in 12 March 2026.

Timeline

20 May 2025

Primary endpoint
12 March 2026

12 March 2026

Quick facts

Lead sponsor	Neola Medical AB
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	20 May 2025
Primary completion	12 March 2026
Estimated completion	12 March 2026
Sites	1 location across Sweden

Drugs / interventions tested

Monitoring

Conditions studied

RDS of Prematurity — all drugs for RDS of Prematurity →
Preterm Birth — all drugs for Preterm Birth →
Lung Diseases — all drugs for Lung Diseases →

Sponsor

Neola Medical AB — full company profile →

Who can join

Adults 1 Day to 14 Days, any sex, with RDS of Prematurity or Preterm Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical pilot study to assess safety and performance of Neola®, a novel lung monitoring device for neonates

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Monitoring

Trials testing the same drug.

NCT07288034 — Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen · Phase 2 · recruiting
NCT07095140 — Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults · NA · recruiting
NCT07091864 — Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma · NA · recruiting
NCT07138326 — Impact on the Absorption of Drugs in Ostomy Patients · recruiting
NCT06279013 — Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-C · NA · recruiting

Other recruiting trials for RDS of Prematurity

Currently open trials in the same condition.

NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
NCT04445571 — Surfactant Administration by Insure or Thin Catheter · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06917326 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Neola Medical AB
Last refreshed: 18 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06917326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing